Cedar Brook Financial Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,792
| Closed | -$222K | – | 19 |
|
|
2024
Q2 | $222K | Sell |
1,792
-4,087
| -70% | -$506K | 1.67% | 21 |
|
|
2024
Q1 | $776K | Sell |
5,879
-69
| -1% | -$9.1K | 0.15% | 156 |
|
|
2023
Q4 | $704K | Sell |
5,948
-31
| -0.5% | -$3.67K | 0.16% | 148 |
|
|
2023
Q3 | $616K | Sell |
5,979
-640
| -10% | -$65.9K | 0.16% | 143 |
|
|
2023
Q2 | $764K | Buy |
6,619
+43
| +0.7% | +$4.96K | 0.18% | 126 |
|
|
2023
Q1 | $700K | Sell |
6,576
-160
| -2% | -$17K | 0.18% | 133 |
|
|
2022
Q4 | $747K | Buy |
6,736
+493
| +8% | +$54.7K | 0.21% | 124 |
|
|
2022
Q3 | $538K | Buy |
6,243
+667
| +12% | +$57.4K | 0.17% | 151 |
|
|
2022
Q2 | $508K | Sell |
5,576
-25
| -0.4% | -$2.28K | 0.16% | 161 |
|
|
2022
Q1 | $460K | Buy |
5,601
+717
| +15% | +$58.9K | 0.12% | 195 |
|
|
2021
Q4 | $374K | Buy |
4,884
+10
| +0.2% | +$766 | 0.1% | 231 |
|
|
2021
Q3 | $366K | Sell |
4,874
-204
| -4% | -$15.3K | 0.11% | 213 |
|
|
2021
Q2 | $395K | Buy |
5,078
+79
| +2% | +$6.15K | 0.11% | 211 |
|
|
2021
Q1 | $368K | Sell |
4,999
-330
| -6% | -$24.3K | 0.13% | 187 |
|
|
2020
Q4 | $416K | Buy |
5,329
+89
| +2% | +$6.95K | 0.15% | 165 |
|
|
2020
Q3 | $415K | Buy |
5,240
+278
| +6% | +$22K | 0.16% | 159 |
|
|
2020
Q2 | $366K | Buy |
4,962
+447
| +10% | +$33K | 0.16% | 164 |
|
|
2020
Q1 | $331K | Sell |
4,515
-513
| -10% | -$37.6K | 0.18% | 159 |
|
|
2019
Q4 | $436K | Buy |
5,028
+405
| +9% | +$35.1K | 0.19% | 150 |
|
|
2019
Q3 | $371K | Buy |
4,623
+288
| +7% | +$23.1K | 0.16% | 180 |
|
|
2019
Q2 | $347K | Sell |
4,335
-138
| -3% | -$11K | 0.16% | 184 |
|
|
2019
Q1 | $355K | Buy |
4,473
+257
| +6% | +$20.4K | 0.17% | 178 |
|
|
2018
Q4 | $307K | Buy |
+4,216
| New | +$307K | 0.19% | 170 |
|